ARCHIVES

Drugs and Targets: FDA extends Lymphoseek label to include mapping in solid tumors

This article is from The Cancer Letter archive.

Vol. 40 No. 41 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

Letter: A Modest Proposal To Abolish FDA

January 26, 1996

Give New Investigators “Special Consideration,” Advisors Tell NCI

June 28, 2002

ASCO Annual Meeting Attendance Tops 25,000, Continuing Fast Growth.

May 18, 2001

Varmus Discusses Grant Policy, Changes in Congress and Ebola

December 12, 2014

In Brief: ASTRO Elects New Officers; ASSIST Coordinators Express Concern Over NCI Plan To Cut Budget

November 27, 1992

House-Senate Conference Agrees On $1 Billion For NCI, Increases For All NIH Organizations

August 3, 1979